For the seventh consecutive year, Rite Aid (NYSE: RAD) will proudly serve as the presenting sponsor of The Skin Cancer Foundation’s annual Road to Healthy Skin Tour. Kicking off today, the Tour runs through August and features local dermatologists coming out into the community to provide free, full-body and potentially life-saving skin cancer screenings to the public.
The Tour’s customized 38-foot recreational vehicle (RV) is gearing up to head across the country recruiting local volunteer dermatologists to provide full-body screenings from the comfort and privacy of one of the RV’s two exam rooms. As The Skin Cancer Foundation’s flagship early detection program, the Tour also aims to raise skin cancer awareness and educate about the importance of prevention and early detection.
“Skin cancer is the most common form of cancer in the United States. The Tour strives to save lives by detecting skin cancers early on and aims to educate the public about skin cancer prevention,” said Skin Cancer Foundation President Perry Robins, MD. “We appreciate Rite Aid’s continued partnership, which enables us to bring this life-saving program to many cities across the country for the seventh year in a row.”
Since 2008, the Road to Healthy Skin Tour has detected more than 7,000 suspected cancers and precancers, including more than 300 cases of melanoma. Over its seven years, the Tour has traveled more than 100,000 miles, winding its way across the United States on its mission to provide easy access to 10-minute screenings that can potentially save lives.“Each year, more than 3.5 million cases of skin cancer are diagnosed across the county, but the good news is, if detected early, it is also one of the most preventable and curable forms of cancer,” said Rite Aid Executive Vice President of Pharmacy Robert I. Thompson, RPh. “Rite Aid is proud to be the presenting sponsor of the Road to Healthy Skin Tour and bring this valuable screening to the communities we serve.”
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts